We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Among the companies with shares expected to actively trade in Friday's session are Pandora Media Inc. (P), Smith & Wesson Holding Corp. (SWHC) and Audience Inc. (ADNC). Apple Inc. (AAPL) is in...
Among the companies with shares expected to actively trade in Friday's session are Audience Inc. (ADNC), Smith & Wesson Holding Corp. (SWHC) and Ulta Salon Cosmetics & Fragrance Inc...
By Kristin Jones Nabi Biopharmaceuticals (NABI) has entered into "advanced discussions" with flu-drug developer Biota Holdings Ltd. (BTA.AU) to name Russell H. Plumb as chief executive of the...
Australian drug development company Biota Holdings Ltd. (BTA.AU) said Monday it plans to merge with Nabi Biopharmaceuticals (NABI) to form a combined company to be listed on Nasdaq. Biota said in...
Australian drug development company Biota Holdings Ltd. (BTA.AU) said Monday it plans to merge with Nabi Biopharmaceuticals (NABI) to form a combined company to be listed on Nasdaq. Biota said in...
AMRI Announces Development and Manufacturing Deal with Biota Holdings Limited PR Newswire ALBANY, N.Y., April 17, 2012 ALBANY, N.Y., April 17, 2012 /PRNewswire/ -- AMRI (NYSE: AMRI), a leading...
Biota Holdings Limited (ASX:BTA) announces that it has received written notifications from GlaxoSmithKline (GSK) regarding royalties for Relenza™ and from Daiichi Sankyo for...
Biota Holdings Limited (ASX:BTA) advises that its wholly owned subsidiary, Biota Scientific Management Pty Ltd, has been awarded a grant to fund the preclinical development of a...
Biota Holdings Limited (ASX:BTA) advises that it has received written notification from Daiichi Sankyo that sales of Inavir® were JPY 3.9 billion and royalties to Biota were AUD...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions